Download Now: Exclusive Guide About India's Potentially Decade-Long $10 Trillion Bull Run...
Here is the latest financial fact sheet of THEMIS MEDICARE. For more details, see the THEMIS MEDICARE quarterly results and THEMIS MEDICARE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.8 |
No. of shares | m | 92.04 |
1 Week | % | 2.4 |
1 Month | % | -3.1 |
1 Year | % | 49.5 |
52 week H/L | Rs | 266.0/131.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
THEMIS MEDICARE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 604 | 458 | 424 | 1,199 | 1,434 | |
Low | Rs | 253 | 140 | 232 | 278 | 692 | |
Sales per share (Unadj.) | Rs | 200.2 | 219.4 | 251.0 | 428.9 | 385.1 | |
Earnings per share (Unadj.) | Rs | -14.2 | 17.3 | 28.5 | 79.2 | 61.8 | |
Diluted earnings per share | Rs | -1.4 | 1.7 | 2.8 | 7.9 | 6.2 | |
Cash flow per share (Unadj.) | Rs | -5.5 | 26.3 | 37.8 | 89.5 | 73.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0.18 | 0.43 | 0.50 | 0.50 | |
Adj. dividends per share | Rs | 0.00 | 0.02 | 0.04 | 0.05 | 0.05 | |
Avg Dividend yield | % | 0 | 0.1 | 0.1 | 0.1 | 0 | |
Book value per share (Unadj.) | Rs | 171.6 | 198.6 | 237.4 | 312.2 | 368.9 | |
Adj. book value per share | Rs | 17.1 | 19.8 | 23.7 | 31.2 | 36.9 | |
Shares outstanding (eoy) | m | 9.18 | 9.19 | 9.19 | 9.20 | 9.20 | |
Price / Sales ratio | x | 2.1 | 1.4 | 1.3 | 1.7 | 2.8 | |
Avg P/E ratio | x | -30.2 | 17.3 | 11.5 | 9.3 | 17.2 | |
P/CF ratio (eoy) | x | -78.1 | 11.4 | 8.7 | 8.2 | 14.5 | |
Price / Book Value ratio | x | 2.5 | 1.5 | 1.4 | 2.4 | 2.9 | |
Dividend payout | % | 0 | 1.0 | 1.5 | 0.6 | 0.8 | |
Avg Mkt Cap | Rs m | 3,934 | 2,747 | 3,014 | 6,794 | 9,784 | |
Total wages/salary | Rs m | 457 | 443 | 400 | 520 | 661 |
THEMIS MEDICARE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,838 | 2,016 | 2,307 | 3,946 | 3,543 | |
Other income | Rs m | 27 | 35 | 36 | 65 | 115 | |
Total revenues | Rs m | 1,864 | 2,051 | 2,343 | 4,012 | 3,658 | |
Gross profit | Rs m | 23 | 357 | 495 | 1,070 | 811 | |
Depreciation | Rs m | 80 | 83 | 85 | 95 | 105 | |
Interest | Rs m | 118 | 129 | 127 | 88 | 96 | |
Profit before tax | Rs m | -149 | 180 | 319 | 953 | 725 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -18 | 21 | 56 | 224 | 156 | |
Profit after tax | Rs m | -130 | 159 | 262 | 729 | 569 | |
Gross profit margin | % | 1.2 | 17.7 | 21.5 | 27.1 | 22.9 | |
Effective tax rate | % | 12.4 | 11.6 | 17.7 | 23.5 | 21.5 | |
Net profit margin | % | -7.1 | 7.9 | 11.4 | 18.5 | 16.1 |
THEMIS MEDICARE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 1,499 | 1,805 | 1,855 | 2,282 | 2,748 | |
Current liabilities | Rs m | 1,467 | 1,548 | 1,283 | 1,235 | 1,494 | |
Net working cap to sales | % | 1.7 | 12.7 | 24.8 | 26.5 | 35.4 | |
Current ratio | x | 1.0 | 1.2 | 1.4 | 1.8 | 1.8 | |
Inventory Days | Days | 63 | 74 | 79 | 62 | 87 | |
Debtors Days | Days | 1,448 | 1,856 | 1,228 | 930 | 1,494 | |
Net fixed assets | Rs m | 1,576 | 1,649 | 1,857 | 2,136 | 2,494 | |
Share capital | Rs m | 92 | 92 | 92 | 92 | 92 | |
"Free" reserves | Rs m | 1,483 | 1,733 | 2,090 | 2,781 | 3,302 | |
Net worth | Rs m | 1,575 | 1,825 | 2,181 | 2,873 | 3,394 | |
Long term debt | Rs m | 94 | 119 | 222 | 239 | 284 | |
Total assets | Rs m | 3,075 | 3,453 | 3,711 | 4,418 | 5,242 | |
Interest coverage | x | -0.3 | 2.4 | 3.5 | 11.9 | 8.6 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.6 | 0.6 | 0.6 | 0.9 | 0.7 | |
Return on assets | % | -0.4 | 8.3 | 10.5 | 18.5 | 12.7 | |
Return on equity | % | -8.3 | 8.7 | 12.0 | 25.4 | 16.8 | |
Return on capital | % | -1.8 | 15.9 | 18.5 | 33.4 | 22.3 | |
Exports to sales | % | 36.3 | 33.7 | 43.1 | 48.2 | 39.4 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 668 | 680 | 995 | 1,903 | 1,395 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 668 | 680 | 995 | 1,903 | 1,395 | |
Fx outflow | Rs m | 44 | 31 | 27 | 118 | 477 | |
Net fx | Rs m | 623 | 648 | 968 | 1,785 | 918 |
THEMIS MEDICARE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 109 | 3 | 570 | 344 | 161 | |
From Investments | Rs m | -37 | -55 | -157 | -156 | -240 | |
From Financial Activity | Rs m | -99 | 67 | -256 | -175 | 1 | |
Net Cashflow | Rs m | -27 | 16 | 157 | 13 | -77 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Dinesh S Patel | COMP SEC: Sangameshwar Iyer | YEAR OF INC: 1969 | BSE CODE: 530199 | FV (Rs): 1 | DIV YIELD (%): 0.0 |
Read: THEMIS MEDICARE 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare THEMIS MEDICARE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.